Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

AHR vs DOC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AHR
American Healthcare REIT, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$8.55B
5Y Perf.+265.9%
DOC
Healthpeak Properties, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$13.56B
5Y Perf.+16.4%

AHR vs DOC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AHR logoAHR
DOC logoDOC
IndustryREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$8.55B$13.56B
Revenue (TTM)$2.20B$2.87B
Net Income (TTM)$27M$222M
Gross Margin20.7%21.2%
Operating Margin7.7%18.3%
Forward P/E66.5x100.1x
Total Debt$1.87B$10.44B
Cash & Equiv.$77M$538M

AHR vs DOCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AHR
DOC
StockFeb 24May 26Return
American Healthcare… (AHR)100365.9+265.9%
Healthpeak Properti… (DOC)100116.4+16.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: AHR vs DOC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AHR leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Healthpeak Properties, Inc. is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
AHR
American Healthcare REIT, Inc.
The Real Estate Income Play

AHR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.4%, EPS growth 73.1%, 3Y rev CAGR 17.9%
  • 295.4% 10Y total return vs DOC's 15.3%
  • Lower volatility, beta 0.23, Low D/E 81.2%, current ratio 0.37x
Best for: growth exposure and long-term compounding
DOC
Healthpeak Properties, Inc.
The Real Estate Income Play

DOC is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 1 yrs, beta 0.52, yield 6.3%
  • Beta 0.52, yield 6.3%, current ratio 1.09x
  • 7.7% margin vs AHR's 1.2%
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthAHR logoAHR11.4% FFO/revenue growth vs DOC's 4.5%
ValueAHR logoAHRLower P/E (66.5x vs 100.1x)
Quality / MarginsDOC logoDOC7.7% margin vs AHR's 1.2%
Stability / SafetyAHR logoAHRBeta 0.23 vs DOC's 0.52, lower leverage
DividendsDOC logoDOC6.3% yield, 1-year raise streak, vs AHR's 1.9%
Momentum (1Y)AHR logoAHR+56.8% vs DOC's +18.8%
Efficiency (ROA)DOC logoDOC1.1% ROA vs AHR's 0.6%, ROIC 2.3% vs 2.4%

AHR vs DOC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AHRAmerican Healthcare REIT, Inc.
FY 2024
Resident Fees and Services
100.0%$1.9B
DOCHealthpeak Properties, Inc.
FY 2025
Outpatient Medical Buildings
46.5%$1.3B
Lab
31.4%$860M
Senior Housing
22.1%$604M

AHR vs DOC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAHRLAGGINGDOC

Income & Cash Flow (Last 12 Months)

DOC leads this category, winning 4 of 6 comparable metrics.

DOC and AHR operate at a comparable scale, with $2.9B and $2.2B in trailing revenue. DOC is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to AHR's 1.2%.

MetricAHR logoAHRAmerican Healthca…DOC logoDOCHealthpeak Proper…
RevenueTrailing 12 months$2.2B$2.9B
EBITDAEarnings before interest/tax$378M$1.6B
Net IncomeAfter-tax profit$27M$222M
Free Cash FlowCash after capex$269M$1.2B
Gross MarginGross profit ÷ Revenue+20.7%+21.2%
Operating MarginEBIT ÷ Revenue+7.7%+18.3%
Net MarginNet income ÷ Revenue+1.2%+7.7%
FCF MarginFCF ÷ Revenue+12.2%+40.2%
Rev. Growth (YoY)Latest quarter vs prior year+9.4%+7.1%
EPS Growth (YoY)Latest quarter vs prior year+11.7%+3.6%
DOC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — AHR and DOC each lead in 3 of 6 comparable metrics.

On an enterprise value basis, DOC's 14.6x EV/EBITDA is more attractive than AHR's 28.9x.

MetricAHR logoAHRAmerican Healthca…DOC logoDOCHealthpeak Proper…
Market CapShares × price$8.6B$13.6B
Enterprise ValueMkt cap + debt − cash$10.3B$23.5B
Trailing P/EPrice ÷ TTM EPS-172.48x195.00x
Forward P/EPrice ÷ next-FY EPS est.66.53x100.10x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple28.87x14.64x
Price / SalesMarket cap ÷ Revenue4.13x4.80x
Price / BookPrice ÷ Book value/share2.84x1.63x
Price / FCFMarket cap ÷ FCF101.67x11.82x
Evenly matched — AHR and DOC each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

AHR leads this category, winning 6 of 9 comparable metrics.

DOC delivers a 2.6% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $1 for AHR. AHR carries lower financial leverage with a 0.81x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOC's 1.26x. On the Piotroski fundamental quality scale (0–9), AHR scores 7/9 vs DOC's 4/9, reflecting strong financial health.

MetricAHR logoAHRAmerican Healthca…DOC logoDOCHealthpeak Proper…
ROE (TTM)Return on equity+1.0%+2.6%
ROA (TTM)Return on assets+0.6%+1.1%
ROICReturn on invested capital+2.4%+2.3%
ROCEReturn on capital employed+4.1%+2.8%
Piotroski ScoreFundamental quality 0–974
Debt / EquityFinancial leverage0.81x1.26x
Net DebtTotal debt minus cash$1.8B$9.9B
Cash & Equiv.Liquid assets$77M$538M
Total DebtShort + long-term debt$1.9B$10.4B
Interest CoverageEBIT ÷ Interest expense1.07x1.78x
AHR leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AHR leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in AHR five years ago would be worth $39,539 today (with dividends reinvested), compared to $8,393 for DOC. Over the past 12 months, AHR leads with a +56.8% total return vs DOC's +18.8%. The 3-year compound annual growth rate (CAGR) favors AHR at 58.1% vs DOC's 3.6% — a key indicator of consistent wealth creation.

MetricAHR logoAHRAmerican Healthca…DOC logoDOCHealthpeak Proper…
YTD ReturnYear-to-date+6.4%+22.9%
1-Year ReturnPast 12 months+56.8%+18.8%
3-Year ReturnCumulative with dividends+295.4%+11.3%
5-Year ReturnCumulative with dividends+295.4%-16.1%
10-Year ReturnCumulative with dividends+295.4%+15.3%
CAGR (3Y)Annualised 3-year return+58.1%+3.6%
AHR leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AHR and DOC each lead in 1 of 2 comparable metrics.

AHR is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than DOC's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOC currently trades 99.1% from its 52-week high vs AHR's 91.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAHR logoAHRAmerican Healthca…DOC logoDOCHealthpeak Proper…
Beta (5Y)Sensitivity to S&P 5000.23x0.52x
52-Week HighHighest price in past year$54.67$19.68
52-Week LowLowest price in past year$31.94$15.70
% of 52W HighCurrent price vs 52-week peak+91.5%+99.1%
RSI (14)Momentum oscillator 0–10049.848.4
Avg Volume (50D)Average daily shares traded2.3M8.0M
Evenly matched — AHR and DOC each lead in 1 of 2 comparable metrics.

Analyst Outlook

DOC leads this category, winning 2 of 2 comparable metrics.

Wall Street rates AHR as "Buy" and DOC as "Buy". Consensus price targets imply 13.5% upside for AHR (target: $57) vs -8.4% for DOC (target: $18). For income investors, DOC offers the higher dividend yield at 6.26% vs AHR's 1.85%.

MetricAHR logoAHRAmerican Healthca…DOC logoDOCHealthpeak Proper…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$56.75$17.86
# AnalystsCovering analysts1140
Dividend YieldAnnual dividend ÷ price+1.9%+6.3%
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS$0.93$1.22
Buyback YieldShare repurchases ÷ mkt cap+0.0%+0.7%
DOC leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

DOC leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). AHR leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.

Best OverallAmerican Healthcare REIT, I… (AHR)Leads 2 of 6 categories
Loading custom metrics...

AHR vs DOC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is AHR or DOC a better buy right now?

For growth investors, American Healthcare REIT, Inc.

(AHR) is the stronger pick with 11. 4% revenue growth year-over-year, versus 4. 5% for Healthpeak Properties, Inc. (DOC). Healthpeak Properties, Inc. (DOC) offers the better valuation at 195. 0x trailing P/E (100. 1x forward), making it the more compelling value choice. Analysts rate American Healthcare REIT, Inc. (AHR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AHR or DOC?

On forward P/E, American Healthcare REIT, Inc.

is actually cheaper at 66. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — AHR or DOC?

Over the past 5 years, American Healthcare REIT, Inc.

(AHR) delivered a total return of +295. 4%, compared to -16. 1% for Healthpeak Properties, Inc. (DOC). Over 10 years, the gap is even starker: AHR returned +295. 4% versus DOC's +15. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AHR or DOC?

By beta (market sensitivity over 5 years), American Healthcare REIT, Inc.

(AHR) is the lower-risk stock at 0. 23β versus Healthpeak Properties, Inc. 's 0. 52β — meaning DOC is approximately 127% more volatile than AHR relative to the S&P 500. On balance sheet safety, American Healthcare REIT, Inc. (AHR) carries a lower debt/equity ratio of 81% versus 126% for Healthpeak Properties, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — AHR or DOC?

By revenue growth (latest reported year), American Healthcare REIT, Inc.

(AHR) is pulling ahead at 11. 4% versus 4. 5% for Healthpeak Properties, Inc. (DOC). On earnings-per-share growth, the picture is similar: American Healthcare REIT, Inc. grew EPS 73. 1% year-over-year, compared to -72. 2% for Healthpeak Properties, Inc.. Over a 3-year CAGR, AHR leads at 17. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AHR or DOC?

Healthpeak Properties, Inc.

(DOC) is the more profitable company, earning 2. 5% net margin versus -1. 8% for American Healthcare REIT, Inc. — meaning it keeps 2. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOC leads at 19. 3% versus 6. 6% for AHR. At the gross margin level — before operating expenses — DOC leads at 22. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AHR or DOC more undervalued right now?

On forward earnings alone, American Healthcare REIT, Inc.

(AHR) trades at 66. 5x forward P/E versus 100. 1x for Healthpeak Properties, Inc. — 33. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AHR: 13. 5% to $56. 75.

08

Which pays a better dividend — AHR or DOC?

All stocks in this comparison pay dividends.

Healthpeak Properties, Inc. (DOC) offers the highest yield at 6. 3%, versus 1. 9% for American Healthcare REIT, Inc. (AHR).

09

Is AHR or DOC better for a retirement portfolio?

For long-horizon retirement investors, American Healthcare REIT, Inc.

(AHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 1. 9% yield, +295. 4% 10Y return). Both have compounded well over 10 years (AHR: +295. 4%, DOC: +15. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AHR and DOC?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AHR is a small-cap quality compounder stock; DOC is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

AHR

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 12%
Run This Screen
Stocks Like

DOC

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AHR and DOC on the metrics below

Revenue Growth>
%
(AHR: 9.4% · DOC: 7.1%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.